The global bioanalytical testing services market was valued at USD 4.73 billion in 2024 and is anticipated to expand at a CAGR of 9.21% from 2025 to 2030. This growth is driven by the rising volume of drug development activities, increasing drug approval processes, growing therapeutic complexity, and a surge in outsourcing of testing services. The emergence of complex therapeutic...